Difficulty: Easy

Average Score: 100%

Therapeutic duplication would be a concern for a patient prescribed both:

Rationale

Ventolin HFA and Xopenex HFA both belong to the class of short-acting beta-agonists (SABAs).

Both Ventolin HFA and Xopenex HFA are used for the relief of bronchospasm in conditions like asthma and COPD, functioning similarly by activating beta-2 adrenergic receptors. This overlap in therapeutic action raises concerns of therapeutic duplication, as using both medications may lead to excessive stimulation of the same receptor pathway, increasing the risk of side effects.

A (Spiriva Respimat and Dulera.) YOUR ANSWER

Spiriva Respimat is a long-acting anticholinergic (LAMA) used for COPD, while Dulera is a combination inhaler that contains a corticosteroid and a long-acting beta-agonist (LABA). Since these medications target different pathways (muscarinic receptors vs. beta-adrenergic receptors), their concurrent use does not constitute therapeutic duplication.

B (Flovent HFA and Incruse Ellipta.) YOUR ANSWER

Flovent HFA is an inhaled corticosteroid (ICS) used for asthma control, and Incruse Ellipta is a LAMA for COPD management. Similar to the previous choice, these medications serve different roles in managing respiratory conditions, minimizing the risk of therapeutic duplication.

D (Serevent Diskus and Atrovent HFA.) YOUR ANSWER

Serevent Diskus is a LABA, while Atrovent HFA is a short-acting anticholinergic (SAMA). These medications operate via distinct mechanisms, targeting different receptors in the respiratory system, and therefore do not pose a risk of therapeutic duplication when prescribed together.

Conclusion

Therapeutic duplication occurs when two medications with similar therapeutic effects are prescribed concurrently, increasing the risk of adverse effects without additional benefit. In this scenario, the only pair that presents this risk is Ventolin HFA and Xopenex HFA, as both are SABAs and provide redundant treatment for bronchospasm. Understanding these distinctions is crucial for safe and effective pharmacotherapy in patients with respiratory conditions.

Related Questions

View all